New developments in sustained-release antihypertensive therapy: Formulation and pharmacokinetic considerations
References (8)
Nifedipine in myocardial ischemia, systemic hypertension, and other cardiovascular disorders
Ann Intern Med
(1986)- et al.
Compliance characteristics of 291 hypertensive patients from a rural midwest area
J Fam Pract
(1983) - et al.
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects
J Clin Pharmacol
(1983) - et al.
Nifedipine: kinetics and dynamics in healthy subjects
Clin Pharmacol Ther
(1984)
There are more references available in the full text version of this article.
Cited by (6)
Picture of the month
2000, Archives of Pediatrics and Adolescent MedicineComparative bioavailability study of two brands of sustained-release nifedipine products in healthy volunteers
1999, Chinese Pharmaceutical JournalOral drug delivery technology: Addressing the solubility/permeability paradigm
1998, Pharmaceutical TechnologyControlled Study with a New Sustained‐Release Formulation of Nifedipine in Essential Hypertensive Patients
1994, The Journal of Clinical Pharmacology
Copyright © 1992 Published by Elsevier Inc.